New Strategies in the Treatment of Ta-T1 Transitional Cell Carcinoma (TCC) of the Bladder

In recent years, there have been many advances in the treatment of superficial bladder cancer. Standard intravesical chemotherapeutic agents can now be delivered more effectively thanks to new technological advances in drug delivery. Local microwave hyperthermia and electromotive drug administration...

Full description

Saved in:
Bibliographic Details
Main Author: Maurizio A. Brausi
Format: Article
Language:English
Published: Wiley 2006-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/tsw.2006.406
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564530897485824
author Maurizio A. Brausi
author_facet Maurizio A. Brausi
author_sort Maurizio A. Brausi
collection DOAJ
description In recent years, there have been many advances in the treatment of superficial bladder cancer. Standard intravesical chemotherapeutic agents can now be delivered more effectively thanks to new technological advances in drug delivery. Local microwave hyperthermia and electromotive drug administration are of particular interest. Research has also shown that different combinations of drugs and sequential drug delivery of two or more different drugs for differing periods of time also increase the effectiveness of possible treatments of superficial bladder cancer. Furthermore, new chemotherapeutic drugs for intravesical use are being investigated in various clinical trials, with gemcitabine showing particularly promising results. Also in the pipeline are new approaches to treatment such as gene therapy, but these will need to be developed much more before they become part of routine practice.
format Article
id doaj-art-4b9ce435feee4e11ac752dfe62a407b7
institution Kabale University
issn 1537-744X
language English
publishDate 2006-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-4b9ce435feee4e11ac752dfe62a407b72025-02-03T01:10:42ZengWileyThe Scientific World Journal1537-744X2006-01-0162632263710.1100/tsw.2006.406New Strategies in the Treatment of Ta-T1 Transitional Cell Carcinoma (TCC) of the BladderMaurizio A. Brausi0AUSL Modena, ItalyIn recent years, there have been many advances in the treatment of superficial bladder cancer. Standard intravesical chemotherapeutic agents can now be delivered more effectively thanks to new technological advances in drug delivery. Local microwave hyperthermia and electromotive drug administration are of particular interest. Research has also shown that different combinations of drugs and sequential drug delivery of two or more different drugs for differing periods of time also increase the effectiveness of possible treatments of superficial bladder cancer. Furthermore, new chemotherapeutic drugs for intravesical use are being investigated in various clinical trials, with gemcitabine showing particularly promising results. Also in the pipeline are new approaches to treatment such as gene therapy, but these will need to be developed much more before they become part of routine practice.http://dx.doi.org/10.1100/tsw.2006.406
spellingShingle Maurizio A. Brausi
New Strategies in the Treatment of Ta-T1 Transitional Cell Carcinoma (TCC) of the Bladder
The Scientific World Journal
title New Strategies in the Treatment of Ta-T1 Transitional Cell Carcinoma (TCC) of the Bladder
title_full New Strategies in the Treatment of Ta-T1 Transitional Cell Carcinoma (TCC) of the Bladder
title_fullStr New Strategies in the Treatment of Ta-T1 Transitional Cell Carcinoma (TCC) of the Bladder
title_full_unstemmed New Strategies in the Treatment of Ta-T1 Transitional Cell Carcinoma (TCC) of the Bladder
title_short New Strategies in the Treatment of Ta-T1 Transitional Cell Carcinoma (TCC) of the Bladder
title_sort new strategies in the treatment of ta t1 transitional cell carcinoma tcc of the bladder
url http://dx.doi.org/10.1100/tsw.2006.406
work_keys_str_mv AT maurizioabrausi newstrategiesinthetreatmentoftat1transitionalcellcarcinomatccofthebladder